Antiviral agents for the suppression of hepatitis B virus (HBV) have been used for treating chronic hepatitis B. However, the emergence of drug-resistant HBV is still a major problem for antiviral treatment. To identify and characterize the drug-resistant HBV, the construction of HBV replicon and in vitro drug susceptibility assay are essential. Here we describe the experimental methods to study drug-resistant HBV.
Ahn, S. H., Park, Y. K. and Kim, K. (2015). Introduction and Sequencing of Patient-isolated HBV RT Sequences into the HBV 1.2-mer Replicon. Bio-protocol 5(8): e1449. DOI: 10.21769/BioProtoc.1449.